Overview
Lori Pai is an Oncologist in Boston, Massachusetts. Dr. Pai is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Her clinical research consists of co-authoring 12 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
860 Washington St Bldg 8, Boston, MA 02111
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Dana-Farber Cancer Institute
Matthew Heeney is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Heeney is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.
Boston Children's Hospital
Monica Hulbert is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Hulbert is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Bone Marrow Transplant.
Rhode Island Hospital
Patrick Mcgann is a Hematologist and an Oncologist in Providence, Rhode Island. Dr. Mcgann is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Anemia, Hemolytic Anemia, and Congenital Hemolytic Anemia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung Cancer
- Lung AdenocarcinomaDr. Pai isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Pai isDistinguished. Learn about Lung Cancer.
- MelanomaDr. Pai isDistinguished. Learn about Melanoma.
- Pleuropulmonary BlastomaDr. Pai isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Pai isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- AstrocytomaDr. Pai isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- EGFR Positive Lung CancerDr. Pai isAdvanced. Learn about EGFR Positive Lung Cancer.
- Embryonal Tumor with Multilayered Rosettes
- EpendymomaDr. Pai isAdvanced. Learn about Ependymoma.
- GlioblastomaDr. Pai isAdvanced. Learn about Glioblastoma.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Pai isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- AgranulocytosisDr. Pai isExperienced. Learn about Agranulocytosis.
- Basal Cell Skin CancerDr. Pai isExperienced. Learn about Basal Cell Skin Cancer.
- Brain TumorDr. Pai isExperienced. Learn about Brain Tumor.
- Choroid Plexus CarcinomaDr. Pai isExperienced. Learn about Choroid Plexus Carcinoma.
- Chromophobe Renal Cell CarcinomaDr. Pai isExperienced. Learn about Chromophobe Renal Cell Carcinoma.